David Rodgers, PhD

David is a Senior Director of Translational Sciences at Foresite Labs, where he leads therapeutics discovery strategy and identifies opportunities for new company creation.

With more than 12 years of biotech experience, David has advanced translational programs across antibody, oligonucleotide, cell therapy, and small molecule modalities, spanning immunology, oncology, infectious disease, and regenerative medicine. Before joining Foresite Labs, he held leadership roles at the Calibr-Skaggs Research Institute, Shoreline Biosciences, and Regulus Therapeutics, where he established early research strategy and built the teams and labs to support growth. He has contributed to more than 30 patents and peer-reviewed publications.

David is an immunologist by training. He earned his PhD in immunology from the University of Glasgow as a Wellcome Trust Fellow and holds a bachelor’s degree from Newcastle University. At Foresite Labs, he applies this experience to evaluating emerging science and shaping it into new therapeutic opportunities.